Home/Comanche Biopharma/Scott Johnson, M.D.

SJ

Scott Johnson, M.D.

Chief Executive Officer & Co-Founder

Comanche Biopharma

Therapeutic Areas

Maternal-Fetal Health Obstetrics Hypertensive Disorders of Pregnancy

Comanche Biopharma Pipeline

Drug	Indication	Phase
CBP-4888	sFlt1-mediated Preterm Preeclampsia	Clinical Development (Phase not specified)

Leadership Team at Comanche Biopharma

Richard Colvin, MD, PhD

Global Head of R&D

John McHutchison, AO, MD

Chairman and Director of Comanche Biopharma Australia

View full Comanche Biopharma profile